{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:16:18Z","timestamp":1791483378456,"version":"4.3.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00535-017-1416-0","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T15:49:09Z","timestamp":1512056949000},"page":"172-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping"],"prefix":"10.1007","volume":"53","author":[{"given":"Yoichi","family":"Kakuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Kinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooru","family":"Shimosegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"key":"1416_CR1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bmj.4.5945.627","volume":"4","author":"DP Jewell","year":"1974","unstructured":"Jewell DP, Truelove SC. Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J. 1974;4:627\u201330.","journal-title":"Br Med J."},{"key":"1416_CR2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","volume":"123","author":"DC Pearson","year":"1995","unstructured":"Pearson DC, May GR, Fick GH, et al. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med. 1995;123:132\u201342.","journal-title":"A meta-analysis. Ann Intern Med."},{"key":"1416_CR3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s00535-003-1139-2","volume":"38","author":"T Hibi","year":"2003","unstructured":"Hibi T, Naganuma M, Kitahora T, et al. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J Gastroenterol. 2003;38:740\u20136.","journal-title":"J Gastroenterol."},{"key":"1416_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2036.2008.03732.x","volume":"28","author":"JP Gisbert","year":"2008","unstructured":"Gisbert JP, Nino P, Cara C, et al. Comparative effectiveness of azathioprine in Crohn\u2019s disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients. Aliment Pharmacol Ther. 2008;28:228\u201338.","journal-title":"Aliment Pharmacol Ther."},{"key":"1416_CR5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ajg.2011.64","volume":"106","author":"KJ Khan","year":"2011","unstructured":"Khan KJ, Dubinsky MC, Ford AC, et al. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011;106:630\u201342.","journal-title":"Am J Gastroenterol."},{"key":"1416_CR6","doi-asserted-by":"publisher","first-page":"CD000067","DOI":"10.1002\/14651858","volume":"10","author":"N Chande","year":"2015","unstructured":"Chande N, Patton PH, Tsoulis DJ, et al. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn\u2019s disease. Cochrane Database Syst Rev. 2015;10:CD000067. \n                        https:\/\/doi.org\/10.1002\/14651858\n                        \n                    .","journal-title":"Cochrane Database Syst Rev."},{"key":"1416_CR7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2013.10.052","volume":"146","author":"R Panaccione","year":"2014","unstructured":"Panaccione R, Ghosh S, Middleton S, et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology. 2014;146:392\u2013400.","journal-title":"Gastroenterology."},{"key":"1416_CR8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease. N Engl J Med. 2010;362:1383\u201395.","journal-title":"N Engl J Med."},{"key":"1416_CR9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cgh.2017.02.005","volume":"15","author":"Y Qiu","year":"2017","unstructured":"Qiu Y, Mao R, Chen BL, et al. Effects of combination therapy with immunomodulators on trough levels and antibodies against tumor necrosis factor antagonists in patients with inflammatory bowel disease: a meta-analysis. Clin Gastroenterol Hepatol. 2017;15:1359\u201372.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1416_CR10","first-page":"873","volume":"23","author":"JB Jun","year":"2005","unstructured":"Jun JB, Cho DY, Kang C, et al. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine. Clin Exp Rheumatol. 2005;23:873\u20136.","journal-title":"Clin Exp Rheumatol."},{"key":"1416_CR11","doi-asserted-by":"crossref","first-page":"e1513","DOI":"10.1097\/MD.0000000000001513","volume":"94","author":"Y Qiu","year":"2015","unstructured":"Qiu Y, Mao R, Zhang SH, et al. Safety profile of thiopurines in Crohn disease: analysis of 893 patient-years follow-up in a Southern China cohort. Medicine. 2015;94:e1513.","journal-title":"Medicine."},{"key":"1416_CR12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1440-1746.2009.05917.x","volume":"24","author":"N Takatsu","year":"2009","unstructured":"Takatsu N, Matsui T, Murakami Y, et al. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2009;24:1258\u201364.","journal-title":"J Gastroenterol Hepatol."},{"key":"1416_CR13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2036.2007.03421.x","volume":"26","author":"O Palmieri","year":"2007","unstructured":"Palmieri O, Latiano A, Bossa F, et al. Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines\u2019 toxicity and efficacy. Aliment Pharmacol Ther. 2007;26:737\u201345.","journal-title":"Aliment Pharmacol Ther."},{"key":"1416_CR14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pds.926","volume":"13","author":"RB Gearry","year":"2004","unstructured":"Gearry RB, Barclay ML, Burt MJ, et al. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Pharmacoepidemiol Drug Saf. 2004;13:563\u20137.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"1416_CR15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","volume":"8","author":"FM Ruemmele","year":"2014","unstructured":"Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease. J Crohns Colitis. 2014;8:1179\u2013207.","journal-title":"J Crohns Colitis."},{"key":"1416_CR16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","volume":"118","author":"MC Dubinsky","year":"2000","unstructured":"Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705\u201313.","journal-title":"Gastroenterology."},{"key":"1416_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2125.2007.02985.x","volume":"65","author":"S Haglund","year":"2008","unstructured":"Haglund S, Taipalensuu J, Peterson C, et al. IMPDH activity in thiopurine-treated patients with inflammatory bowel disease-relation to TPMT activity and metabolite concentrations. Br J Clin Pharmacol. 2008;65:69\u201377.","journal-title":"Br J Clin Pharmacol."},{"key":"1416_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/clpt.1987.4","volume":"41","author":"L Lennard","year":"1987","unstructured":"Lennard L, Van Loon JA, Lilleyman JS, et al. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther. 1987;41:18\u201325.","journal-title":"Clin Pharmacol Ther."},{"key":"1416_CR19","first-page":"199","volume":"34","author":"E Schutz","year":"1996","unstructured":"Schutz E, Gummert J, Armstrong VW, et al. Azathioprine pharmacogenetics: the relationship between 6-thioguanine nucleotides and thiopurine methyltransferase in patients after heart and kidney transplantation. Eur J Clin Chem Clin Biochem. 1996;34:199\u2013205.","journal-title":"Eur J Clin Chem Clin Biochem."},{"key":"1416_CR20","first-page":"959","volume":"58","author":"M Lorenz","year":"2012","unstructured":"Lorenz M, Weise A, Prause S, et al. Development and validation of a rapid and reliable method for TPMT genotyping using real-time PCR. Clin Lab. 2012;58:959\u201371.","journal-title":"Clin Lab."},{"key":"1416_CR21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.ejhg.5201647","volume":"14","author":"TV Nasedkina","year":"2006","unstructured":"Nasedkina TV, Fedorova OE, Glotov AS, et al. Rapid genotyping of common deficient thiopurine S-methyltransferase alleles using the DNA-microchip technique. Eur J Hum Genet. 2006;14:991\u20138.","journal-title":"Eur J Hum Genet."},{"key":"1416_CR22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.2010.320","volume":"89","author":"MV Relling","year":"2011","unstructured":"Relling MV, Gardner EE, Sandborn WJ, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther. 2011;89:387\u201391.","journal-title":"Clin Pharmacol Ther."},{"key":"1416_CR23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.ftd.0000179839.71138.6d","volume":"28","author":"LJ Derijks","year":"2006","unstructured":"Derijks LJ, Gilissen LP, Engels LG, et al. Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease. Ther Drug Monit. 2006;28:45\u201350.","journal-title":"Ther Drug Monit."},{"key":"1416_CR24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ab.2007.12.033","volume":"375","author":"S Kurtovic","year":"2008","unstructured":"Kurtovic S, Grehn L, Karlsson A, et al. Glutathione transferase activity with a novel substrate mimics the activation of the prodrug azathioprine. Anal Biochem. 2008;375:339\u201344.","journal-title":"Anal Biochem."},{"key":"1416_CR25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/138161210790112773","volume":"16","author":"LJ Derijks","year":"2010","unstructured":"Derijks LJ, Wong DR. Pharmacogenetics of thiopurines in inflammatory bowel disease. Curr Pharm Des. 2010;16:145\u201354.","journal-title":"Curr Pharm Des."},{"key":"1416_CR26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/apt.13559","volume":"43","author":"W Moon","year":"2016","unstructured":"Moon W, Loftus EV Jr. Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2016;43:863\u201383.","journal-title":"Aliment Pharmacol Ther."},{"key":"1416_CR27","first-page":"2872","volume":"35","author":"JA Nelson","year":"1975","unstructured":"Nelson JA, Carpenter JW, Rose LM, et al. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine. Cancer Res. 1975;35:2872\u20138.","journal-title":"Cancer Res."},{"key":"1416_CR28","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/0006-2952(86)90623-4","volume":"35","author":"CR Fairchild","year":"1986","unstructured":"Fairchild CR, Maybaum J, Kennedy KA. Concurrent unilateral chromatid damage and DNA strand breakage in response to 6-thioguanine treatment. Biochem Pharmacol. 1986;35:3533\u201341.","journal-title":"Biochem Pharmacol."},{"key":"1416_CR29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4049\/jimmunol.176.1.640","volume":"176","author":"D Poppe","year":"2006","unstructured":"Poppe D, Tiede I, Fritz G, et al. Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins. J Immunol. 2006;176:640\u201351.","journal-title":"J Immunol."},{"key":"1416_CR30","first-page":"651","volume":"32","author":"RM Weinshilboum","year":"1980","unstructured":"Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet. 1980;32:651\u201362.","journal-title":"Am J Hum Genet."},{"key":"1416_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008571-199608000-00001","volume":"6","author":"EY Krynetski","year":"1996","unstructured":"Krynetski EY, Tai HL, Yates CR, et al. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics. 1996;6:279\u201390.","journal-title":"Pharmacogenetics."},{"key":"1416_CR32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0016-5085(00)70354-4","volume":"118","author":"JF Colombel","year":"2000","unstructured":"Colombel JF, Ferrari N, Debuysere H, et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn\u2019s disease and severe myelosuppression during azathioprine therapy. Gastroenterology. 2000;118:1025\u201330.","journal-title":"Gastroenterology."},{"key":"1416_CR33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.dld.2004.09.029","volume":"37","author":"AF Al Hadithy","year":"2005","unstructured":"Al Hadithy AF, de Boer NK, Derijks LJ, et al. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations. Dig Liver Dis. 2005;37:282\u201397.","journal-title":"Dig Liver Dis."},{"key":"1416_CR34","first-page":"S30","volume":"3","author":"EG Seidman","year":"2003","unstructured":"Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Disord. 2003;3:S30\u20138.","journal-title":"Rev Gastroenterol Disord."},{"key":"1416_CR35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.clpt.2003.12.001","volume":"75","author":"U Nygaard","year":"2004","unstructured":"Nygaard U, Toft N, Schmiegelow K. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity. Clin Pharmacol Ther. 2004;75:274\u201381.","journal-title":"Clin Pharmacol Ther."},{"key":"1416_CR36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/MPG.0000000000000455","volume":"59","author":"U Kopylov","year":"2014","unstructured":"Kopylov U, Amre D, Theoret Y, et al. Thiopurine metabolite ratios for monitoring therapy in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2014;59:511\u20135.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"1416_CR37","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1365-2036.2002.01353.x","volume":"16","author":"A Ansari","year":"2002","unstructured":"Ansari A, Hassan C, Duley J, et al. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment Pharmacol Ther. 2002;16:1743\u201350.","journal-title":"Aliment Pharmacol Ther."},{"key":"1416_CR38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1098-1004(1998)12:3<177::AID-HUMU5>3.0.CO;2-E","volume":"12","author":"CS Moureyre de la","year":"1998","unstructured":"de la Moureyre CS, Debuysere H, Sabbagh N, et al. Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis. Hum Mutat. 1998;12:177\u201385.","journal-title":"Hum Mutat."},{"key":"1416_CR39","doi-asserted-by":"crossref","first-page":"46428","DOI":"10.1038\/srep46428","volume":"7","author":"YPH Iu","year":"2017","unstructured":"Iu YPH, Helander S, Kahlin AZ, et al. One amino acid makes a difference\u2014characterization of a new TPMT allele and the influence of SAM on TPMT stability. Sci Rep. 2017;7:46428.","journal-title":"Sci Rep."},{"key":"1416_CR40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/FPC.0b013e3283097328","volume":"18","author":"S Ujiie","year":"2008","unstructured":"Ujiie S, Sasaki T, Mizugaki M, et al. Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2-*24). Pharmacogenet Genomics. 2008;18:887\u201393.","journal-title":"Pharmacogenet Genomics."},{"key":"1416_CR41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2036.2007.03301.x","volume":"25","author":"JW Winter","year":"2007","unstructured":"Winter JW, Gaffney D, Shapiro D, et al. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2007;25:1069\u201377.","journal-title":"Aliment Pharmacol Ther."},{"key":"1416_CR42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/humu.9450","volume":"27","author":"E Schaeffeler","year":"2006","unstructured":"Schaeffeler E, Eichelbaum M, Reinisch W, et al. Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22)-association with decreased enzyme function. Hum Mutat. 2006;27:976.","journal-title":"Hum Mutat."},{"key":"1416_CR43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00008571-200404000-00006","volume":"14","author":"M Lindqvist","year":"2004","unstructured":"Lindqvist M, Haglund S, Almer S, et al. Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity. Pharmacogenetics. 2004;14:261\u20135.","journal-title":"Pharmacogenetics."},{"key":"1416_CR44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/FPC.0b013e3282f85e47","volume":"18","author":"RL Roberts","year":"2008","unstructured":"Roberts RL, Gearry RB, Bland MV, et al. Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity. Pharmacogenet Genomics. 2008;18:434\u20138.","journal-title":"Pharmacogenet Genomics."},{"key":"1416_CR45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1067\/mcp.2000.108674","volume":"68","author":"L Yan","year":"2000","unstructured":"Yan L, Zhang S, Eiff B, et al. Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis. Clin Pharmacol Ther. 2000;68:210\u20139.","journal-title":"Clin Pharmacol Ther."},{"key":"1416_CR46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ejca.2004.10.027","volume":"41","author":"C Brouwer","year":"2005","unstructured":"Brouwer C, De Abreu RA, Keizer-Garritsen JJ, et al. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects. Eur J Cancer. 2005;41:613\u201323.","journal-title":"Eur J Cancer."},{"key":"1416_CR47","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ejca.2009.05.013","volume":"45","author":"V Charasson","year":"2009","unstructured":"Charasson V, Hillaire-Buys D, Solassol I, et al. Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model. Eur J Cancer. 2009;45:2391\u2013401.","journal-title":"Eur J Cancer."},{"key":"1416_CR48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clinbiochem.2009.09.003","volume":"43","author":"N Karas-Kuzelicki","year":"2010","unstructured":"Karas-Kuzelicki N, Milek M, Mlinaric-Rascan I. MTHFR and TYMS genotypes influence TPMT activity and its differential modulation in males and females. Clin Biochem. 2010;43:37\u201342.","journal-title":"Clin Biochem."},{"key":"1416_CR49","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2217\/pgs.12.70","volume":"13","author":"P Dorababu","year":"2012","unstructured":"Dorababu P, Naushad SM, Linga VG, et al. Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL. Pharmacogenomics. 2012;13:1001\u20138.","journal-title":"Pharmacogenomics."},{"key":"1416_CR50","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1038\/ncomms9018","volume":"6","author":"M Nagasaki","year":"2015","unstructured":"Nagasaki M, Yasuda J, Katsuoka F, et al. Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals. Nat Commun. 2015;6:8018.","journal-title":"Nat Commun."},{"key":"1416_CR51","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1038\/hgv.2015.50","volume":"2","author":"Y Yamaguchi-Kabata","year":"2015","unstructured":"Yamaguchi-Kabata Y, Nariai N, Kawai Y, et al. iJGVD: an integrative Japanese genome variation database based on whole-genome sequencing. Hum Genome Var. 2015;2:15050.","journal-title":"Hum Genome Var."},{"key":"1416_CR52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00535-008-2307-1","volume":"44","author":"K Uchiyama","year":"2009","unstructured":"Uchiyama K, Nakamura M, Kubota T, et al. Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine\/6-mercaptopurine treatment. J Gastroenterol. 2009;44:197\u2013203.","journal-title":"J Gastroenterol."},{"key":"1416_CR53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2125.2009.03405.x","volume":"68","author":"SK Kham","year":"2009","unstructured":"Kham SK, Soh CK, Aw DC, et al. TPMT*26 (208F\u2013>L), a novel mutation detected in a Chinese. Br J Clin Pharmacol. 2009;68:120\u20133.","journal-title":"Br J Clin Pharmacol."},{"key":"1416_CR54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2133\/dmpk.21.332","volume":"21","author":"T Sasaki","year":"2006","unstructured":"Sasaki T, Goto E, Konno Y, et al. Three novel single nucleotide polymorphisms of the human thiopurine S-methyltransferase gene in Japanese individuals. Drug Metab Pharmacokinet. 2006;21:332\u20136.","journal-title":"Drug Metab Pharmacokinet."},{"key":"1416_CR55","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2169\/internalmedicine.47.1268","volume":"47","author":"H Ban","year":"2008","unstructured":"Ban H, Andoh A, Tanaka A, et al. Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease. Intern Med. 2008;47:1645\u20138.","journal-title":"Intern Med."},{"key":"1416_CR56","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1124\/mol.62.6.1321","volume":"62","author":"PR Wielinga","year":"2002","unstructured":"Wielinga PR, Reid G, Challa EE, et al. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol. 2002;62:1321\u201331.","journal-title":"Mol Pharmacol."},{"key":"1416_CR57","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-07-6790","volume":"68","author":"P Krishnamurthy","year":"2008","unstructured":"Krishnamurthy P, Schwab M, Takenaka K, et al. Transporter-mediated protection against thiopurine-induced hematopoietic toxicity. Cancer Res. 2008;68:4983\u20139.","journal-title":"Cancer Res."},{"key":"1416_CR58","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00535-010-0248-y","volume":"45","author":"H Ban","year":"2010","unstructured":"Ban H, Andoh A, Imaeda H, et al. The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease. J Gastroenterol. 2010;45:1014\u201321.","journal-title":"J Gastroenterol."},{"key":"1416_CR59","first-page":"950","volume":"58","author":"Y Tanaka","year":"2017","unstructured":"Tanaka Y. Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and ABCC4 variants in Japanese childhood acute lymphoblastic leukemia. Rinsho Ketsueki. 2017;58:950\u20136.","journal-title":"Rinsho Ketsueki."},{"key":"1416_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2017.12","author":"Y Tanaka","year":"2017","unstructured":"Tanaka Y, Nakadate H, Kondoh K, et al. Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia. Pharmacogenomics J. 2017. \n                        https:\/doi.org\/10.1038\/tpj.2017.12\n                        \n                    .","journal-title":"Pharmacogenomics J."},{"key":"1416_CR61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0009-8981(79)90410-8","volume":"97","author":"SL Holmes","year":"1979","unstructured":"Holmes SL, Turner BM, Hirschhorn K. Human inosine triphosphatase: catalytic properties and population studies. Clin Chim Acta. 1979;97:143\u201353.","journal-title":"Clin Chim Acta."},{"key":"1416_CR62","doi-asserted-by":"crossref","first-page":"18695","DOI":"10.1074\/jbc.M011084200","volume":"276","author":"S Lin","year":"2001","unstructured":"Lin S, McLennan AG, Ying K, et al. Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the ITPA gene. J Biol Chem. 2001;276:18695\u2013701.","journal-title":"J Biol Chem."},{"key":"1416_CR63","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-200403000-00006","volume":"14","author":"AM Marinaki","year":"2004","unstructured":"Marinaki AM, Ansari A, Duley JA, et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics. 2004;14:181\u20137.","journal-title":"Pharmacogenetics."},{"key":"1416_CR64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14740330903426151","volume":"9","author":"G Stocco","year":"2010","unstructured":"Stocco G, Crews KR, Evans WE. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status. Expert Opin Drug Saf. 2010;9:23\u201337.","journal-title":"Expert Opin Drug Saf."},{"key":"1416_CR65","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00008571-200411000-00010","volume":"14","author":"RB Gearry","year":"2004","unstructured":"Gearry RB, Roberts RL, Barclay ML, et al. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenetics. 2004;14:779\u201381.","journal-title":"Pharmacogenetics."},{"key":"1416_CR66","first-page":"1664","volume":"54","author":"JM Dieren van","year":"2005","unstructured":"van Dieren JM, van Vuuren AJ, Kusters JG, et al. ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients. Gut. 2005;54:1664.","journal-title":"Gut."},{"key":"1416_CR67","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.2007.03412.x","volume":"26","author":"JM Dieren Van","year":"2007","unstructured":"Van Dieren JM, Hansen BE, Kuipers EJ, et al. Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2007;26:643\u201352.","journal-title":"Aliment Pharmacol Ther."},{"key":"1416_CR68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2133\/dmpk.24.557","volume":"24","author":"M Kudo","year":"2009","unstructured":"Kudo M, Saito Y, Sasaki T, et al. Genetic variations in the HGPRT, ITPA, IMPDH1, IMPDH2, and GMPS genes in Japanese individuals. Drug Metab Pharmacokinet. 2009;24:557\u201364.","journal-title":"Drug Metab Pharmacokinet."},{"key":"1416_CR69","first-page":"3665","volume":"125","author":"Q Zhu","year":"2012","unstructured":"Zhu Q, Cao Q. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine. Chin Med J (Engl). 2012;125:3665\u201370.","journal-title":"Chin Med J (Engl)."},{"key":"1416_CR70","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ng.3060","volume":"46","author":"SK Yang","year":"2014","unstructured":"Yang SK, Hong M, Baek J, et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet. 2014;46:1017\u201320.","journal-title":"Nat Genet."},{"key":"1416_CR71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bjh.13518","volume":"171","author":"Y Tanaka","year":"2015","unstructured":"Tanaka Y, Kato M, Hasegawa D, et al. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia. Br J Haematol. 2015;171:109\u201315.","journal-title":"Br J Haematol."},{"key":"1416_CR72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/tpj.2015.43","volume":"16","author":"Y Kakuta","year":"2016","unstructured":"Kakuta Y, Naito T, Onodera M, et al. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. Pharmacogenomics J. 2016;16:280\u20135.","journal-title":"Pharmacogenomics J."},{"key":"1416_CR73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00535-015-1142-4","volume":"51","author":"A Asada","year":"2016","unstructured":"Asada A, Nishida A, Shioya M, et al. NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease. J Gastroenterol. 2016;51:22\u20139.","journal-title":"J Gastroenterol."},{"key":"1416_CR74","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/apt.13796","volume":"44","author":"X Zhu","year":"2016","unstructured":"Zhu X, Wang XD, Chao K, et al. NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2016;44:967\u201375.","journal-title":"Aliment Pharmacol Ther."},{"key":"1416_CR75","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/jcpt.12420","volume":"41","author":"Z Ailing","year":"2016","unstructured":"Ailing Z, Jing Y, Jingli L, et al. Further evidence that a variant of the gene NUDT15 may be an important predictor of azathioprine-induced toxicity in Chinese subjects: a case report. J Clin Pharm Ther. 2016;41:572\u20134.","journal-title":"J Clin Pharm Ther."},{"key":"1416_CR76","doi-asserted-by":"crossref","first-page":"185","DOI":"10.12809\/hkmj154783","volume":"22","author":"FC Wong","year":"2016","unstructured":"Wong FC, Leung AW, Kwok JS, et al. NUDT15 variant and thiopurine-induced leukopenia in Hong Kong. Hong Kong Med J. 2016;22:185\u20137.","journal-title":"Hong Kong Med J."},{"key":"1416_CR77","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/tpj.2015.75","volume":"16","author":"DC Liang","year":"2016","unstructured":"Liang DC, Yang CP, Liu HC, et al. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. Pharmacogenomics J. 2016;16:536\u20139.","journal-title":"Pharmacogenomics J."},{"key":"1416_CR78","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/jgh.13494","volume":"32","author":"SA Shah","year":"2017","unstructured":"Shah SA, Paradkar M, Desai D, et al. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients. J Gastroenterol Hepatol. 2017;32:620\u20134.","journal-title":"J Gastroenterol Hepatol."},{"key":"1416_CR79","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.3324\/haematol.2015.134775","volume":"101","author":"K Chiengthong","year":"2016","unstructured":"Chiengthong K, Ittiwut C, Muensri S, et al. NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia. Haematologica. 2016;101:e24\u20136.","journal-title":"Haematologica."},{"key":"1416_CR80","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3508","volume":"48","author":"T Moriyama","year":"2016","unstructured":"Moriyama T, Nishii R, Perez-Andreu V, et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet. 2016;48:367\u201373.","journal-title":"Nat Genet."},{"key":"1416_CR81","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14532","author":"AM Soler","year":"2017","unstructured":"Soler AM, Olano N, Mendez Y, et al. TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay. Br J Haematol. 2017. \n                        https:\/doi.org\/10.1111\/bjh.14532\n                        \n                    .","journal-title":"Br J Haematol."},{"key":"1416_CR82","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5217\/ir.2017.15.3.328","volume":"15","author":"T Sato","year":"2017","unstructured":"Sato T, Takagawa T, Kakuta Y, et al. NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases. Intest Res. 2017;15:328\u201337.","journal-title":"Intest Res."},{"key":"1416_CR83","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2017.283","author":"ES Yi","year":"2017","unstructured":"Yi ES, Choi YB, Choi R, et al. NUDT15 variants cause hematopoietic toxicity with low 6-TGN levels in children with acute lymphoblastic leukemia. Cancer Res Treat. 2017. doi: \n                        https:\/\/doi.org\/10.4143\/crt.2017.283\n                        \n                    .","journal-title":"Cancer Res Treat."},{"key":"1416_CR84","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0006-291X(03)00864-7","volume":"305","author":"JP Cai","year":"2003","unstructured":"Cai JP, Ishibashi T, Takagi Y, et al. Mouse MTH2 protein which prevents mutations caused by 8-oxoguanine nucleotides. Biochem Biophys Res Commun. 2003;305:1073\u20137.","journal-title":"Biochem Biophys Res Commun."},{"key":"1416_CR85","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1038\/ncomms8871","volume":"6","author":"M Carter","year":"2015","unstructured":"Carter M, Jemth AS, Hagenkort A, et al. Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2. Nat Commun. 2015;6:7871.","journal-title":"Nat Commun."},{"key":"1416_CR86","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0000000000000282","volume":"27","author":"T Moriyama","year":"2017","unstructured":"Moriyama T, Nishii R, Lin TN, et al. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2017;27:236\u20139.","journal-title":"Pharmacogenet Genomics."},{"key":"1416_CR87","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1158\/0008-5472.CAN-16-0584","volume":"76","author":"NC Valerie","year":"2016","unstructured":"Valerie NC, Hagenkort A, Page BD, et al. NUDT15 hydrolyzes 6-Thio-DeoxyGTP to mediate the anticancer efficacy of 6-thioguanine. Cancer Res. 2016;76:5501\u201311.","journal-title":"Cancer Res."},{"key":"1416_CR88","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/FPC.0000000000000274","volume":"27","author":"HT Kim","year":"2017","unstructured":"Kim HT, Choi R, Won HH, et al. NUDT15 genotype distributions in the Korean population. Pharmacogenet Genomics. 2017;27:197\u2013200.","journal-title":"Pharmacogenet Genomics."},{"key":"1416_CR89","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/MIB.0000000000001148","volume":"23","author":"K Chao","year":"2017","unstructured":"Chao K, Wang X, Cao Q, et al. Combined detection of NUDT15 variants could highly predict thiopurine-induced leukopenia in Chinese patients with inflammatory bowel disease: a multicenter analysis. Inflamm Bowel Dis. 2017;23:1592\u20139.","journal-title":"Inflamm Bowel Dis."},{"key":"1416_CR90","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2188\/jea.JE20150268","volume":"26","author":"S Kuriyama","year":"2016","unstructured":"Kuriyama S, Yaegashi N, Nagami F, et al. The Tohoku Medical Megabank Project: design and mission. J Epidemiol. 2016;26:493\u2013511.","journal-title":"J Epidemiol."},{"key":"1416_CR91","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood-2017-05-782383","volume":"130","author":"T Moriyama","year":"2017","unstructured":"Moriyama T, Yang YL, Nishii R, et al. Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry. Blood. 2017;130:1209\u201312.","journal-title":"Blood."},{"key":"1416_CR92","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gut.34.8.1081","volume":"34","author":"WR Connell","year":"1993","unstructured":"Connell WR, Kamm MA, Ritchie JK, et al. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27\u00a0years of experience. Gut. 1993;34:1081\u20135.","journal-title":"Gut."}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-017-1416-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T02:12:37Z","timestamp":1517451157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-017-1416-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,30]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1007\/s00535-017-1416-0","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,30]]}}}